Numerous studies have reported elevated neuronal activation in conditions associated with AD, including in cognitively normal carriers of the APOE4 allele [38–41], pre-symptomatic carriers of genetic mutations for familial AD [42], and patients with amnestic mild cognitive impairment (aMCI) [43–45]. This evidence concerns the gene APOE and Alzheimer disease.